REQUEST A DEMO
Total
USD $0.00
Search more companies

Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm) (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jw Euvipharm Joint Stock Company Profile Updated: March 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm) is an enterprise based in Vietnam. Its main office is in Not Disclosed. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on July 24, 2013. 97 (2024) employees currently work for Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm). In its most recent financial highlights, the company reported a net sales revenue increase of 22.18% in 2024. There was a total growth of 6.87% in Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm)’s total assets over the same period. In 2024, Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm)’s net profit margin increased by 16.15%.

Legal Address
Binh Tien 2 Hamlet, Duc Hoa Commune
Not Disclosed; Tay Ninh Province;

Contact Details: Purchase the Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm) report to view the information.

Website: http://www.jw-euvipharm.com

Basic Information
Total Employees:
Purchase the Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm) report to view the information.
Financial Auditors:
Purchase the Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm) report to view the information.
Incorporation Date:
July 24, 2013
Key Executives
Purchase this report to view the information.
Advisor
Company Performance
Financial values in the chart are available after Jw Euvipharm Joint Stock Company (Công Ty Cổ Phần Jw Euvipharm) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
22.18%
Total Operating Revenue
22.18%
Operating Profit
N/A
EBITDA
1722.59%
Net Profit/Loss for the Period
85.27%
Total Assets
6.87%
Total Equity
-12.66%
Operating Profit Margin
N/A
Net Profit Margin
16.15%
Return on Equity (ROE)
-74.69%
Debt / Equity
49576000%
Quick Ratio
74950%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?